Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations

INTRODUCTION: Following a Phase III, randomized, double-blind, placebo (PBO)-controlled, multinational study in subjects with mucopolysaccharidosis IVA (MPS IVA), enzyme replacement therapy (ERT) of elosulfase alfa has been approved in several countries. The study was designed to evaluate safety and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Expert Opin Orphan Drugs
Main Authors: Tomatsu, Shunji, Sawamoto, Kazuki, Shimada, Tsutomu, Bober, Michael B., Kubaski, Francyne, Yasuda, Eriko, Mason, Robert W., Khan, Shaukat, Alméciga-Díaz, Carlos J., Barrera, Luis A., Mackenzie, William G., Orii, Tadao
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4788508/
https://ncbi.nlm.nih.gov/pubmed/26973801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/21678707.2015.1086640
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados